| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.003 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.21 | 0.005 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.007 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |